在肺动脉瘤下arachnoid出血患者的体内葡萄糖评估:一个前性观察可行性研究的协议
Hanna Schenck1,2, Inger de Ridder3, Erik Gommer4,5
1Department of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands. hanna.schenck@mumc.nl.
Pilot and feasibility studies
|December 2, 2025
概括
在体内葡萄糖测量表明,它是预测延迟脑缺血症 (DCI) 的可行的生物标志物,在动脉瘤下arachnoid出血 (aSAH) 之后. 与传统的系统性标记物相比,这种微创技术可能会提供更好的洞察力.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 微循环研究 微循环研究
背景情况:
- 动脉瘤下arachnoid出血 (aSAH) 后的延迟大脑缺血症 (DCI) 是发病率和死亡率的主要原因.
- 目前的DCI生物标志物有限,阻碍了预测和管理.
- 对于血管健康至关重要的葡萄糖与DCI病变产生有关.
研究的目的:
- 评估aSAH患者体内葡萄糖度测量的可行性.
- 为了评估随着时间的推移与DCI发展相关的葡萄糖标记物的变化.
- 为了将体内葡萄糖度测量与体外标记进行DCI预测的比较.
主要方法:
- 对30名aSAH患者进行前性观察性研究.
- 使用侧流暗场 (SDF) 成像 (子语言和结膜) 测量体内葡萄糖的厚度.
- 从血液样本量化出活体葡萄糖的分解;在中风后的2周内重复测量.
主要成果:
- 通过技术,操作和安全参数评估体内葡萄糖测量的可行性.
- 混合模型分析比较了语言下和结膜下测量的可行性.
- 二次分析探讨了使用混合效应物流回归的DCI对体内与体外葡萄糖测量的响应性.
结论:
- 通过SDF成像进行体内葡萄糖度评估是评估微循环的一种最少的侵入性方法.
- 结膜测量可能比系统标记更好地反映大脑微血管变化.
- 在体内可行的葡萄糖测量可以作为aSAH患者中DCI的有价值的,可预测的生物标志物.
相关概念视频
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
240
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
240
01:14Glycocalyx and its Functions
7.8K
The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
7.8K